Edition:
United States

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

66.27USD
2:08pm EDT
Change (% chg)

$-0.26 (-0.39%)
Prev Close
$66.53
Open
$66.40
Day's High
$67.31
Day's Low
$65.42
Volume
11,874
Avg. Vol
39,378
52-wk High
$76.29
52-wk Low
$21.95

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.83 December 18 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 1 1 2 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.60 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.08 0.20 0.00 0.72
Quarter Ending Sep-18 3 0.08 0.20 0.00 0.72
Year Ending Dec-18 5 2.86 10.00 0.00 2.71
Year Ending Dec-19 4 2.53 10.00 0.00 1.99
Earnings (per share)
Quarter Ending Jun-18 4 -0.83 -0.59 -0.95 -0.68
Quarter Ending Sep-18 4 -0.85 -0.59 -1.01 -0.66
Year Ending Dec-18 5 -3.58 -2.94 -4.06 -2.87
Year Ending Dec-19 4 -3.67 -1.80 -4.71 -3.97

Historical Surprises

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.41 0.03 0.38 93.16
Quarter Ending Dec-17 0.36 0.28 0.08 21.28
Quarter Ending Sep-17 0.62 0.43 0.18 29.48
Quarter Ending Jun-17 0.78 0.44 0.34 43.19
Quarter Ending Mar-17 0.82 0.35 0.46 56.67

Consensus Estimates Trend

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.08 0.08 0.41 0.41 0.72
Quarter Ending Sep-18 0.08 0.08 0.41 0.41 0.72
Year Ending Dec-18 2.86 2.86 3.49 3.16 2.71
Year Ending Dec-19 2.53 2.53 3.03 2.73 1.99

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 1
Quarter Ending Sep-18 0 0 0 1
Year Ending Dec-18 0 0 0 4
Year Ending Dec-19 0 0 0 2
Earnings